Lactobacillus rhamnosus GG-derived extracellular vesicles improve cholestatic liver injury by regulating the gut microbiota and bile acid metabolism

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Chemical Engineering Journal

• Publication date

  2025-11-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.cej.2025.170547
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary biliary cholangitis.

  2024cited by this paper
• Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway.

  2024cited by this paper
• Bile acid metabolism and signaling in liver disease.

  2024cited by this paper
• Advances in research on microbial conjugated linoleic acid bioconversion.

  2023cited by this paper
• Dietary Fiber and Its Potential Role in Obesity: A Focus on Modulating the Gut Microbiota.

  2023cited by this paper
• Farnesoid X Receptor Plays a Key Role in Ochratoxin A-Induced Nephrotoxicity by Targeting Ferroptosis In Vivo and In Vitro.

  2023cited by this paper
• Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis.

  2023cited by this paper
• 24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ

  2023cited by this paper
• Exploring Extracellular Vesicles of Probiotic Yeast as Carriers of Biologically Active Molecules Transferred to Human Intestinal Cells

  2023cited by this paper
• Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis

  2023cited by this paper
• Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease

  2023cited by this paper
• Loss of toll-like receptor 5 potentiates spontaneous hepatocarcinogenesis in farnesoid X receptor–deficient mice

  2023cited by this paper
• Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice

  2023cited by this paper
• Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis

  2023cited by this paper
• Bacterial extracellular vesicles and associated functional proteins in fermented dairy products with Lacticaseibacillus paracasei

  2023cited by this paper
• Metformin alleviates liver fibrosis in mice by enriching Lactobacillus sp. MF-1 in the gut microbiota.

  2023cited by this paper
• Gut Lactobacillus and Probiotics Lactobacillus lactis/rhamnosis Ameliorate Liver Fibrosis in Prevention and Treatment

  2023cited by this paper
• Gut Microbiota Deficiency Exacerbates Liver Injury in Bile Duct Ligated Mice via Inflammation and Lipid Metabolism

  2023cited by this paper
• A review on the use of prebiotics in ulcerative colitis.

  2023cited by this paper
• Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis

  2023cited by this paper
• Transcriptome and Gut Microbiota Profiling Analysis of ANIT-Induced Cholestasis and the Effects of Da-Huang-Xiao-Shi Decoction Intervention

  2022cited by this paper
• Caffeic acid phenethyl ester suppresses intestinal FXR signaling and ameliorates nonalcoholic fatty liver disease by inhibiting bacterial bile salt hydrolase activity

  2022cited by this paper
• Effects of Intestinal FXR-Related Molecules on Intestinal Mucosal Barriers in Biliary Tract Obstruction

  2022cited by this paper
• Extracellular vesicles derived from Lactobacillus plantarum restore chemosensitivity through the PDK2-mediated glucose metabolic pathway in 5-FU-resistant colorectal cancer cells

  2022cited by this paper
• Bile acid conjugation deficiency causes hypercholanemia, hyperphagia, islet dysfunction, and gut dysbiosis in mice

  2022cited by this paper
• Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling.

  2022cited by this paper
• The microbiota and the gut–liver axis in primary sclerosing cholangitis

  2022cited by this paper
• The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer

  2021cited by this paper
• The interaction among gut microbes, the intestinal barrier and short chain fatty acids

  2021cited by this paper
• Bacterial membrane vesicles and phages in blood after consumption of lacticaseibacillus rhamnosus JB-1

  2021cited by this paper
• Microbiota‐derived extracellular vesicles in interkingdom communication in the gut

  2021cited by this paper
• Review: microbial transformations of human bile acids

  2021cited by this paper
• Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis

  2021cited by this paper
• Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease

  2021cited by this paper
• Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice

  2020cited by this paper
• Molecular Physiology of Bile Acid Signaling in Health, Disease and Aging.

  2020cited by this paper
• Obeticholic acid improves fetal bile acid profile in a mouse model of gestational hypercholanemia

  2020cited by this paper
• Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor

  2020cited by this paper
• Enhanced Microbial Bile Acid Deconjugation and Impaired Ileal Uptake in Pregnancy Repress Intestinal Regulation of Bile Acid Synthesis

  2019cited by this paper
• Farnesoid X Receptor Suppresses Lgr5+ Cancer Stem Cell Proliferation.

  2019cited by this paper
• Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids.

  2019cited by this paper
• Metabolic Messengers: fibroblast growth factor 15/19

  2019cited by this paper
• The Klotho proteins in health and disease

  2018cited by this paper
• Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives

  2018cited by this paper
• NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice.

  2017cited by this paper
• Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

  2015cited by this paper
• New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond.

  2015cited by this paper
• AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Mechanism of Tissue-Specific Farnesoid X Receptor in Suppressing the Expression of Genes in Bile-Acid Synthesis in Mice

  2012cited by this paper
• Physiological, pharmacological and clinical features of the multidrug resistance protein 2.

  2005cited by this paper
• New insights into the biology and pharmacology of the multidrug resistance protein (MRP) from gene knockout models.

  1999cited by this paper
• Function, evolution and structure of multidrug resistance protein (MRP).

  1997cited by this paper
• Multidrug resistance mediated by the multidrug resistance protein (MRP) gene.

  1996cited by this paper
• Role of multidrug resistance protein (MRP) in glutathione S-conjugate transport in mammalian cells.

  1996cited by this paper
• Primary biliary cirrhosis.

  1968cited by this paper

• Extracellular vesicles ameliorate intrauterine adhesion through Nrf2/GPX4-mediated ferroptosis suppression.

  2026cites this paper